RxDoctor Payments Data

Allison Moore, DO

Internal Medicine · Largo, FLNPI 1225463649

Payments from drug & device makers

$740in general payments, 2019–2025

Across 34 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mylan Specialty L.p.$116
  • Shionogi Inc$96
  • Pfizer$72
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$67
  • Viatris Specialty LLC$60
  • Stryker$40
  • plus $289 from 11 others

What the payments were for

  • Food & beverage$740100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$740 in reported general payments places this provider in the 60th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Medicare billing

Part B allowed, 2024
$127,978
Medicare patients
340
Services billed
1,383

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban157$46,637
EntrestoSacubitril/Valsartan48$16,454
JardianceEmpagliflozin42$11,843
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$8,362
BrilintaTicagrelor21$4,812
Atorvastatin Calcium295$4,046
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate16$3,897
Dabigatran EtexilateDabigatran Etexilate Mesylate20$3,845
Fluphenazine Hcl15$3,462
Divalproex Sodium91$3,121
Memantine Hcl95$3,030
TradjentaLinagliptin19$2,907
Duloxetine Hcl67$2,560
Desvenlafaxine Succinate ErDesvenlafaxine Succinate50$2,452
Gabapentin128$2,322

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$72$46,637157 claims
NovartisEntresto$34$16,45448 claims
AstraZenecaBrilinta$31$4,81221 claims
MerckSteglatro$31$2,12911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,530 internal medicine providers in Florida.

Other internal medicine in Largo

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →